3-iodobenzylguanidine has been researched along with Hypokalemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hashimoto, H; Murakami, H; Nakamura, K; Sonoo, T | 1 |
| Fukuhara, T; Kanagawa, K; Kanda, M; Maekawa, I; Minoguchi, M; Miyake, T; Onozawa, M; Takahata, M; Yamamoto, Y | 1 |
2 other study(ies) available for 3-iodobenzylguanidine and Hypokalemia
| Article | Year |
|---|---|
Pheochromocytoma crisis in a patient with newly diagnosed neurofibromatosis type 1.
Topics: 3-Iodobenzylguanidine; Adrenalectomy; Alcoholism; Catecholamines; Chlorides; Humans; Hypokalemia; Hyponatremia; Hypophosphatemia; Male; Metanephrine; Middle Aged; Neurofibromatosis 1; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals; Tachycardia, Ventricular; Water-Electrolyte Imbalance | 2021 |
Hypokalemic rhabdomyolysis due to WDHA syndrome caused by VIP-producing composite pheochromocytoma: a case in neurofibromatosis type 1.
Topics: 3-Iodobenzylguanidine; Achlorhydria; Adrenal Gland Neoplasms; Diarrhea; Female; Humans; Hypokalemia; Middle Aged; Neurofibromatosis 1; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals; Rhabdomyolysis; Syndrome; Tomography, X-Ray Computed; Vasoactive Intestinal Peptide | 2005 |